RHOT1 and Parkinson disease: Combined with previous evidence showing that mitochondria in PD neurons accumulate abnormally high levels of Miro1, delaying mitophagy and that reducing Miro1 levels can mitigate neurodegeneration in PD models, these findings highlight proteins involved in mitochondrial Ca2+ flow as promising targets for anti-PD therapies242,243.